The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

PAREXEL International Corp

Nasdaq: PRXL
Last

(U.S.) $69.25

Today's change+0.85 +1.24%
Updated July 29 2:58 PM EDT. Delayed by at least 15 minutes.
 

PAREXEL International Corp

Nasdaq: PRXL
Last

(U.S.) $69.25

Today's change+0.85 +1.24%
Updated July 29 2:58 PM EDT. Delayed by at least 15 minutes.

PAREXEL International Corp Hits New 20-day High

PAREXEL International Corp is up today by (U.S.)$0.85 or 1.24% to (U.S.)$69.25 and setting a new 20-day high. Over the last five days, shares have gained 4.73% and are currently 4.73% off of the 52-week high. Shares have outperformed the S&P 500 by 19.04% during the last year.

Key company metrics

  • Open(U.S.) $68.38
  • Previous close(U.S.) $68.40
  • High(U.S.) $69.42
  • Low(U.S.) $68.12
  • Bid / Ask(U.S.) $69.25 / (U.S.) $69.28
  • YTD % change+24.64%
  • Volume493,080
  • Average volume (10-day)1,288,436
  • Average volume (1-month)774,736
  • Average volume (3-month)606,214
  • 52-week range(U.S.) $52.19 to (U.S.) $72.69
  • Beta1.22
  • Trailing P/E25.32×
  • P/E 1 year forward25.00×
  • Forward PEG1.40×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.74
Updated July 29 2:58 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.65%

Based on its net profit margin of 6.65%, PAREXEL International Corp is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX1.32%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue576575574585
Total other revenue--------
Total revenue576575574585
Gross profit158169174185
Total cost of revenue418406400400
Total operating expense522522520526
Selling / general / administrative889999103
Research & development--------
Depreciation / amortization21202021
Interest expense (income), net operating--------
Unusual expense (income)------0
Other operating expenses, total--------
Operating income54535459
Interest income (expense), net non-operating-2-2-2-2
Gain (loss) on sale of assets--------
Other--------
Income before tax54545556
Income after tax38393740
Income tax, total16151816
Net income38393740
Total adjustments to net income--------
Net income before extra. items38393740
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items38393740
Inc. avail. to common incl. extra. items38393740
Diluted net income38393740
Dilution adjustment0------
Diluted weighted average shares56565657
Diluted EPS excluding extraordinary itemsvalue per share0.680.700.670.70
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.680.700.670.69